看不见的敌人:多种药物抗菌素耐药性机制在阴性ESKAPE病原体中的机制
Giedrė Valdonė Sakalauskienė1, Lina Malcienė1, Edgaras Stankevičius1
1Institute of Physiology and Pharmacology, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Antibiotics (Basel, Switzerland)
|January 25, 2025
概括
格拉姆阴性ESKAPE病原体的多药抗菌素耐药性 (AMR) 是全球主要的健康威胁. 了解耐药机制,如药物排放和向修改,对于开发新疗法至关重要.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 多种药物抗菌素耐药性 (AMR) 在治疗感染方面构成了重大挑战,特别是来自格兰负ESKAPE病原体的感染.
- 逃生病原体 (菌杆菌,黄金葡萄球菌,肺炎菌,宝曼菌, Pseudomonas aeruginosa, Enterobacter spp.) 没有被发现. 由于阻力增加,它们是优先考虑的.
- COVID-19 流行病加剧了这种威胁,同时感染导致患者的治疗结果较差,死亡率增加.
研究的目的:
- 审查推动格拉姆阴性ESKAPE细菌中AMR的复杂机制.
- 专注于Acinetobacter baumannii,Klebsiella pneumoniae,Pseudomonas aeruginosa,以及Enterobacter spp. 这三种细菌,这些细菌是最常见的.
- 突出了解这些机制对于开发新疗法的重要性.
主要方法:
- 关于ESKAPE病原体中抗菌素耐药性的科学文章和报告的文献综述.
- 对关键细菌耐药机制的分析.
- 综合关于药物吸收,酶降解,标修改和排泄系统的信息.
主要成果:
- 格拉姆阴性ESKAPE细菌采用不同的策略来抵抗抗生素.
- 机制包括降低药物透性,抗生素失活酶,改变药物点和活跃的排泄.
- 这些机制有助于当前治疗的有效性下降.
结论:
- 对格兰负ESKAPE病原体中AMR机制的全面了解至关重要.
- 这些知识对于设计新的治疗策略至关重要.
- 在这些优先病原体中解决AMR对于减少全球疾病负担和死亡率至关重要.
更多相关视频
相关概念视频
Antibiotic Selection
52.2K
Overview
52.2K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Bacterial Transformation
55.1K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
55.1K
Genomic DNA in Prokaryotes
43.4K
The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Genomic Diversity in Bacteria
Although bacterial genomes are much...
43.4K
Carrier-Mediated Transport
239
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
239


